Clinical Trial Update: Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study comparing three oral formulations for hormone replacement therapy in postmenopausal women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Oral hormone replacement therapy formulations (three formulations)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Menopause, Healthy | Phase 1 | Status: COMPLETED